Vivos Therapeutics (VVOS) Loans and Notes Receivables (2019 - 2021)
Historic Loans and Notes Receivables for Vivos Therapeutics (VVOS) over the last 3 years, with Q3 2021 value amounting to $61864.0.
- Vivos Therapeutics' Loans and Notes Receivables changed N/A to $61864.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $61864.0, marking a year-over-year change of. This contributed to the annual value of $84000.0 for FY2020, which is 82.18% down from last year.
- According to the latest figures from Q3 2021, Vivos Therapeutics' Loans and Notes Receivables is $61864.0.
- In the past 5 years, Vivos Therapeutics' Loans and Notes Receivables ranged from a high of $84696.0 in Q4 2019 and a low of $56732.0 during Q2 2021
- Its 3-year average for Loans and Notes Receivables is $74397.6, with a median of $84000.0 in 2020.
- Data for Vivos Therapeutics' Loans and Notes Receivables shows a peak YoY increase of 82.18% (in 2020) and a maximum YoY decrease of 82.18% (in 2020) over the last 5 years.
- Quarter analysis of 3 years shows Vivos Therapeutics' Loans and Notes Receivables stood at $84696.0 in 2019, then decreased by 0.82% to $84000.0 in 2020, then fell by 26.35% to $61864.0 in 2021.
- Its Loans and Notes Receivables stands at $61864.0 for Q3 2021, versus $56732.0 for Q2 2021 and $84696.0 for Q1 2021.